Euro Manganese Updates on Progress Across Key Business Activities

Euro Manganese Inc. hosted U.S. Ambassador Nicholas Merrick at its Chvaletice Manganese Project and Demonstration Plant in the Czech Republic. The visit underscored the project’s alignment with North American and European supply chain diversification, referencing an International Energy Agency report that projects the Czech Republic could supply approximately 5% of global high-purity manganese capacity by 2035. Management clarified that the visit does not constitute an endorsement of the project or the company.

In corporate governance updates, James Connolly formally joined the board, while Dr. David Dreisinger resigned from his director role to serve as a consultant. The company also announced an extension of the 2026 Annual General Meeting deadline to November 15, 2026. No new production volumes, cost metrics, financial results, or permitting updates were disclosed in the release.

Euro Manganese Inc. (EMN) issued a routine political and governance update, highlighting an ambassador visit standard for projects designated as strategic under the EU Critical Raw Materials Act. The company also announced a board shuffle that replaces a technical expert with an operations and financing veteran.

The stock has declined approximately 80% from its January 2026 peak, a move that has fully priced in liquidity crunch and going concern risk. This news does not alter the fundamental capital needs or near-term execution timeline for the project.

Euro Manganese Inc. (EMN) operates the Chvaletice Manganese Project in the Czech Republic, its flagship asset. This site features a tailings reprocessing facility designed to produce high-purity manganese sulphate monohydrate (HPMSM) and high-purity electrolytic manganese metal (HPEMM). The project holds strategic designation from the Czech government as a Strategic Deposit and is recognized as a Strategic Project under the EU Critical Raw Materials Act.

The company also owns the Bécancour Plant in Quebec, Canada. A scoping study for the facility has been completed, while a feasibility study remains on hold pending financing.